chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Lymphadenopathy, Muscular weakness, Myalgia, Pain in extremity
Clinical narrative: Appetite pretty much zero; Lost 8-10 pounds in three weeks; skin senstivity; achey body; Super tired; Feet hurt; Abdomen tightness; Diarrhea / loose stool; Tingling sensation; Numbness; Felt like tired muscles all over the body; Joint pains; Swollen lymph node under armpit; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), MUSCULAR WEAKNESS (Felt like tired muscles all over the body), PAIN IN EXTREMITY (Feet hurt) and ABDOMINAL DISCOMFORT (Abdomen tightness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.     On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph node under armpit). On 27-Mar-2021, the patient experienced PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), MUSCULAR WEAKNESS (Felt like tired muscles all over the body), DIARRHOEA (Diarrhea / loose stool) and ARTHRALGIA (Joint pains). On 05-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (Abdomen tightness). On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (Feet hurt) and FATIGUE (Super tired). On 01-May-2021, the patient experienced SENSITIVE SKIN (skin senstivity) and MYALGIA (achey body). On an unknown date, the patient experienced DECREASED APPETITE (Appetite pretty much zero) and WEIGHT DECREASED (Lost 8-10 pounds in three weeks). On 08-Apr-2021, ARTHRALGIA (Joint pains) had resolved. At the time of the report, PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), MUSCULAR WEAKNESS (Felt like tired muscles all over the body), PAIN IN EXTREMITY (Feet hurt), DECREASED APPETITE (Appetite pretty much zero), WEIGHT DECREASED (Lost 8-10 pounds in three weeks), LYMPHADENOPATHY (Swollen lymph node under armpit) and FATIGUE (Super tired) was resolving and ABDOMINAL DISCOMFORT (Abdomen tightness) and DIARRHOEA (Diarrhea / loose stool) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment details was not provided. The patient reports that she felt fine for a week post vaccination except swollen lymph nodes and for two weeks the symptoms were bad then started to get better in third week but still had abdomen tightness and loose stool. She also felt sensation in her body kept changing.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Initial Addition Info Received on 27-Apr-2021 and it contains reporter address  AE start date, additional AE, medication taken and consumer saying that : I feel much better now and able to live a normal life but I'm not 100% back to baseline.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Sensitive skin, Weight decreased
Clinical narrative: Appetite pretty much zero; Lost 8-10 pounds in three weeks; skin senstivity; achey body; Super tired; Feet hurt; Abdomen tightness; Diarrhea / loose stool; Tingling sensation; Numbness; Felt like tired muscles all over the body; Joint pains; Swollen lymph node under armpit; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), MUSCULAR WEAKNESS (Felt like tired muscles all over the body), PAIN IN EXTREMITY (Feet hurt) and ABDOMINAL DISCOMFORT (Abdomen tightness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.     On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph node under armpit). On 27-Mar-2021, the patient experienced PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), MUSCULAR WEAKNESS (Felt like tired muscles all over the body), DIARRHOEA (Diarrhea / loose stool) and ARTHRALGIA (Joint pains). On 05-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (Abdomen tightness). On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (Feet hurt) and FATIGUE (Super tired). On 01-May-2021, the patient experienced SENSITIVE SKIN (skin senstivity) and MYALGIA (achey body). On an unknown date, the patient experienced DECREASED APPETITE (Appetite pretty much zero) and WEIGHT DECREASED (Lost 8-10 pounds in three weeks). On 08-Apr-2021, ARTHRALGIA (Joint pains) had resolved. At the time of the report, PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), MUSCULAR WEAKNESS (Felt like tired muscles all over the body), PAIN IN EXTREMITY (Feet hurt), DECREASED APPETITE (Appetite pretty much zero), WEIGHT DECREASED (Lost 8-10 pounds in three weeks), LYMPHADENOPATHY (Swollen lymph node under armpit) and FATIGUE (Super tired) was resolving and ABDOMINAL DISCOMFORT (Abdomen tightness) and DIARRHOEA (Diarrhea / loose stool) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment details was not provided. The patient reports that she felt fine for a week post vaccination except swollen lymph nodes and for two weeks the symptoms were bad then started to get better in third week but still had abdomen tightness and loose stool. She also felt sensation in her body kept changing.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Initial Addition Info Received on 27-Apr-2021 and it contains reporter address  AE start date, additional AE, medication taken and consumer saying that : I feel much better now and able to live a normal life but I'm not 100% back to baseline.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Vaccination site mass
Clinical narrative: Small golf-ball size lump on my arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Small golf-ball size lump on my arm at injection site) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 037B21A) for COVID-19 vaccination.     The patient's past medical history included Pneumonia (pneumonia or some virus) from 03-Mar-2021 to 01-May-2021 and COVID-19 on 22-Jun-2021.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced VACCINATION SITE MASS (Small golf-ball size lump on my arm at injection site). On 21-Apr-2021, VACCINATION SITE MASS (Small golf-ball size lump on my arm at injection site) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jun-2021, Antibody test: inconclusive (Inconclusive) Blood donation- Antibody Test.         Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-080407 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Added patient demographics,relevant medical history(pneumonia,COVID-19),and event stop date.Updated outcome of the event.; Sender's Comments:  MOD-2021-080407:wife case
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of slight headache and a few chills in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 16, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient had a slight headache and a few chills. The patient treated with Tylenol (paracetamol), at an unspecified dose and frequency. At the time of the report, slight headache and a few chills outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medications taken by the patient: not provided. This case linked to MOD-2021-080404 (patient link).
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness on Movement 3 weeks after Second Dose; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness on Movement 3 weeks after Second Dose) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and Unknown) for COVID-19 vaccination.     Concomitant products included CLONAZEPAM (KLONOPIN) for an unknown indication.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Dizziness on Movement 3 weeks after Second Dose). At the time of the report, DIZZINESS (Dizziness on Movement 3 weeks after Second Dose) outcome was unknown. Not Provided          No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-080301 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080301:crosslinked
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Blepharospasm, Bruxism, Dyspnoea, Palpitations
Clinical narrative: Experience slight Shortness of breath; Heart palpitations; Twitching in his right eye; Teeth grinding at night; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Experience slight Shortness of breath), BLEPHAROSPASM (Twitching in his right eye), BRUXISM (Teeth grinding at night) and PALPITATIONS (Heart palpitations) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced BLEPHAROSPASM (Twitching in his right eye) and BRUXISM (Teeth grinding at night). On an unknown date, the patient experienced DYSPNOEA (Experience slight Shortness of breath) and PALPITATIONS (Heart palpitations). At the time of the report, DYSPNOEA (Experience slight Shortness of breath), BLEPHAROSPASM (Twitching in his right eye), BRUXISM (Teeth grinding at night) and PALPITATIONS (Heart palpitations) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that he had the eye twitch before when he drinks any caffeine. No relevant concomitant medications were reported. No treatment information was reported..
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Diagnosed with covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with covid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced COVID-19 (Diagnosed with covid). On 15-Apr-2021, COVID-19 (Diagnosed with covid) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, SARS-CoV-2 test: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore, heavy arm for about 2 days.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore, heavy arm for about 2 days.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore, heavy arm for about 2 days.). At the time of the report, PAIN IN EXTREMITY (sore, heavy arm for about 2 days.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-080444 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080444:dose 2
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Muscle spasms; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle spasms) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced MUSCLE SPASMS (Muscle spasms). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Muscle spasms) outcome was unknown. Not Provided          40 minutes after receiving the vaccine, patient had muscles spasms.  Concomitant medications were not reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-080360 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up received and does not contain any significant information: Mailing Address updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080360:1st dose event
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: a little achey; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (a little achey) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (a little achey). At the time of the report, PAIN (a little achey) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.    This case was linked to MOD-2021-080278 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspepsia, Pain
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of DYSPEPSIA (Heartburn) and PAIN (Bee Sting Sensation from Chest and Nipple line, up to the top of his head) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced DYSPEPSIA (Heartburn) and PAIN (Bee Sting Sensation from Chest and Nipple line, up to the top of his head). The patient was treated with CALCIUM CARBONATE (TUMS ANTACID) at a dose of 1 dosage form. At the time of the report, DYSPEPSIA (Heartburn) and PAIN (Bee Sting Sensation from Chest and Nipple line, up to the top of his head) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. Treatment also Included Patient had 2 Glasses of Milk after event begins. Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Follow-up information received contains non-significant information. On 03-Jun-2021: Follow-up information received contains non-significant information.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Patient had burning pain from toes to brain; Body ache; Aching in patient's thigh muscle in her both legs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Patient had burning pain from toes to brain), PAIN (Body ache) and PAIN IN EXTREMITY (Aching in patient's thigh muscle in her both legs) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A2109 and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021 at 12:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PAIN (Patient had burning pain from toes to brain) and PAIN (Body ache). In March 2021, the patient experienced PAIN IN EXTREMITY (Aching in patient's thigh muscle in her both legs). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL (TYLENOL PM) at an unspecified dose and frequency. On 11-Mar-2021, PAIN (Patient had burning pain from toes to brain) had resolved. On 12-Mar-2021, PAIN (Body ache) had resolved. At the time of the report, PAIN IN EXTREMITY (Aching in patient's thigh muscle in her both legs) had not resolved.            No concomitant medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow-up received on 19-JUL-2021 and contains significant information updated outcome of event pain in legs was changed from unknown to not recovered or resolved.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Influenza, Limb discomfort, Nausea
Clinical narrative: Mild injection site pain; Flu symptoms; slept for up to 23 hours; Pressure in the legs and hips; Fever (101F); Nausea; Generalized sore and achy joints; Severe Headaches; Tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu symptoms), SOMNOLENCE (slept for up to 23 hours), LIMB DISCOMFORT (Pressure in the legs and hips), PYREXIA (Fever (101F)) and NAUSEA (Nausea) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, AMLODIPINE, SIMVASTATIN, METOPROLOL and ALLOPURINOL.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 17-Apr-2021, the patient experienced INFLUENZA (Flu symptoms), SOMNOLENCE (slept for up to 23 hours), LIMB DISCOMFORT (Pressure in the legs and hips), PYREXIA (Fever (101F)), NAUSEA (Nausea), ARTHRALGIA (Generalized sore and achy joints), HEADACHE (Severe Headaches) and VACCINATION SITE PAIN (Tenderness at injection site). On an unknown date, the patient experienced VACCINATION SITE PAIN (Mild injection site pain). On 19-Apr-2021, INFLUENZA (Flu symptoms), LIMB DISCOMFORT (Pressure in the legs and hips), PYREXIA (Fever (101F)), NAUSEA (Nausea), ARTHRALGIA (Generalized sore and achy joints) and HEADACHE (Severe Headaches) outcome was unknown. At the time of the report, SOMNOLENCE (slept for up to 23 hours), VACCINATION SITE PAIN (Tenderness at injection site) and VACCINATION SITE PAIN (Mild injection site pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Somnolence, Vaccination site pain
Clinical narrative: Mild injection site pain; Flu symptoms; slept for up to 23 hours; Pressure in the legs and hips; Fever (101F); Nausea; Generalized sore and achy joints; Severe Headaches; Tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu symptoms), SOMNOLENCE (slept for up to 23 hours), LIMB DISCOMFORT (Pressure in the legs and hips), PYREXIA (Fever (101F)) and NAUSEA (Nausea) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, AMLODIPINE, SIMVASTATIN, METOPROLOL and ALLOPURINOL.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 17-Apr-2021, the patient experienced INFLUENZA (Flu symptoms), SOMNOLENCE (slept for up to 23 hours), LIMB DISCOMFORT (Pressure in the legs and hips), PYREXIA (Fever (101F)), NAUSEA (Nausea), ARTHRALGIA (Generalized sore and achy joints), HEADACHE (Severe Headaches) and VACCINATION SITE PAIN (Tenderness at injection site). On an unknown date, the patient experienced VACCINATION SITE PAIN (Mild injection site pain). On 19-Apr-2021, INFLUENZA (Flu symptoms), LIMB DISCOMFORT (Pressure in the legs and hips), PYREXIA (Fever (101F)), NAUSEA (Nausea), ARTHRALGIA (Generalized sore and achy joints) and HEADACHE (Severe Headaches) outcome was unknown. At the time of the report, SOMNOLENCE (slept for up to 23 hours), VACCINATION SITE PAIN (Tenderness at injection site) and VACCINATION SITE PAIN (Mild injection site pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Pain, Vaccination site pain
Clinical narrative: feeling pain; fingers are numb; The shoulder that got the shot also numb and pain; feeling pain on the right arm were got the shot; The shoulder that got the shot also numb and pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (feeling pain), HYPOAESTHESIA (fingers are numb), HYPOAESTHESIA (The shoulder that got the shot also numb and pain), VACCINATION SITE PAIN (feeling pain on the right arm were got the shot) and ARTHRALGIA (The shoulder that got the shot also numb and pain) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN (feeling pain), HYPOAESTHESIA (fingers are numb), HYPOAESTHESIA (The shoulder that got the shot also numb and pain), VACCINATION SITE PAIN (feeling pain on the right arm were got the shot) and ARTHRALGIA (The shoulder that got the shot also numb and pain). The patient was treated with PARACETAMOL (TYLENOL) on 08-Apr-2021 for Pain, at a dose of 1 dosage form. At the time of the report, PAIN (feeling pain), HYPOAESTHESIA (fingers are numb), HYPOAESTHESIA (The shoulder that got the shot also numb and pain), VACCINATION SITE PAIN (feeling pain on the right arm were got the shot) and ARTHRALGIA (The shoulder that got the shot also numb and pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information, if any, was not provided by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Eye irritation, Fatigue, Hypersomnia, Multiple allergies
Clinical narrative: little cough; eyes was burning couple days, so bad she had to used solution; little fatigue; sleeping more, 14 hours; still has bit of cough, and the allergies; nose running constantly; This spontaneous case was reported by a patient and describes the occurrence of RHINORRHOEA (nose running constantly), COUGH (little cough), EYE IRRITATION (eyes was burning couple days, so bad she had to used solution), FATIGUE (little fatigue) and HYPERSOMNIA (sleeping more, 14 hours) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced RHINORRHOEA (nose running constantly). On an unknown date, the patient experienced COUGH (little cough), EYE IRRITATION (eyes was burning couple days, so bad she had to used solution), FATIGUE (little fatigue), HYPERSOMNIA (sleeping more, 14 hours) and MULTIPLE ALLERGIES (still has bit of cough, and the allergies). At the time of the report, RHINORRHOEA (nose running constantly), COUGH (little cough), EYE IRRITATION (eyes was burning couple days, so bad she had to used solution), FATIGUE (little fatigue), HYPERSOMNIA (sleeping more, 14 hours) and MULTIPLE ALLERGIES (still has bit of cough, and the allergies) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was provided by the reporter. No concomitant medication was provided by the reporter. No lab data was provided by the reporter   This case was linked to MOD-2021-080422 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: little cough; eyes was burning couple days, so bad she had to used solution; little fatigue; sleeping more, 14 hours; still has bit of cough, and the allergies; nose running constantly; This spontaneous case was reported by a patient and describes the occurrence of RHINORRHOEA (nose running constantly), COUGH (little cough), EYE IRRITATION (eyes was burning couple days, so bad she had to used solution), FATIGUE (little fatigue) and HYPERSOMNIA (sleeping more, 14 hours) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced RHINORRHOEA (nose running constantly). On an unknown date, the patient experienced COUGH (little cough), EYE IRRITATION (eyes was burning couple days, so bad she had to used solution), FATIGUE (little fatigue), HYPERSOMNIA (sleeping more, 14 hours) and MULTIPLE ALLERGIES (still has bit of cough, and the allergies). At the time of the report, RHINORRHOEA (nose running constantly), COUGH (little cough), EYE IRRITATION (eyes was burning couple days, so bad she had to used solution), FATIGUE (little fatigue), HYPERSOMNIA (sleeping more, 14 hours) and MULTIPLE ALLERGIES (still has bit of cough, and the allergies) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was provided by the reporter. No concomitant medication was provided by the reporter. No lab data was provided by the reporter   This case was linked to MOD-2021-080422 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Lip swelling, Mouth swelling, Swelling
Clinical narrative: Swollen Lips; Swollen Mouth; Swollen Nose; Hard to Breathe; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen Lips), MOUTH SWELLING (Swollen Mouth), SWELLING (Swollen Nose) and DYSPNOEA (Hard to Breathe) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced LIP SWELLING (Swollen Lips), MOUTH SWELLING (Swollen Mouth), SWELLING (Swollen Nose) and DYSPNOEA (Hard to Breathe). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, LIP SWELLING (Swollen Lips), MOUTH SWELLING (Swollen Mouth), SWELLING (Swollen Nose) and DYSPNOEA (Hard to Breathe) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other treatment medications included Steroids Injection Concomitant product information, if any, was not provided by the reporter.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysphonia, Dyspnoea, Fatigue, Hyperhidrosis
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of dysphonia (voice changed and it sounded husky and cracked), dyspnea (shortness of breath), influenza-like illness (flu-like symptoms), hyperhidrosis (sweaty) and dizziness (dizzy/lightheaded) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 16, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 16, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 16, 2021, patient had dyspnea (shortness of breath) and dizziness (dizzy/lightheaded). On Apr 17, 2021, patient experienced dysphonia (voice changed and it sounded husky and cracked), influenza-like illness (flu-like symptoms), hyperhidrosis (sweaty) and fatigue (tired). The patient treated with Tylenol (paracetamol), at an unspecified dose and frequency. At the time of the report, dysphonia (voice changed and it sounded husky and cracked), dyspnea (shortness of breath), influenza-like illness (flu-like symptoms), hyperhidrosis (sweaty), dizziness (dizzy/lightheaded) and fatigue (tired) outcome: unknown. The reporter did not provide any causality assessments or concomitant product use. Action taken with mRNA-1273 in response to events: not applicable. This case linked to MOD-2021-080388 (patient link).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of dysphonia (voice changed and it sounded husky and cracked), dyspnea (shortness of breath), influenza-like illness (flu-like symptoms), hyperhidrosis (sweaty) and dizziness (dizzy/lightheaded) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 16, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 16, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 16, 2021, patient had dyspnea (shortness of breath) and dizziness (dizzy/lightheaded). On Apr 17, 2021, patient experienced dysphonia (voice changed and it sounded husky and cracked), influenza-like illness (flu-like symptoms), hyperhidrosis (sweaty) and fatigue (tired). The patient treated with Tylenol (paracetamol), at an unspecified dose and frequency. At the time of the report, dysphonia (voice changed and it sounded husky and cracked), dyspnea (shortness of breath), influenza-like illness (flu-like symptoms), hyperhidrosis (sweaty), dizziness (dizzy/lightheaded) and fatigue (tired) outcome: unknown. The reporter did not provide any causality assessments or concomitant product use. Action taken with mRNA-1273 in response to events: not applicable. This case linked to MOD-2021-080388 (patient link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Vaccination site swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 044A21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE SWELLING (Vaccination site swelling). At the time of the report, VACCINATION SITE SWELLING (Vaccination site swelling) outcome was unknown. Not Provided. Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication details was reported. No treatment medication details was reported. This case was linked to US-MODERNATX, INC.-MOD-2021-080387 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-080387:husband case.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: red circle on the arm until 19Apr2021; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE ERYTHEMA (red circle on the arm until 19Apr2021) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No medical history was reported by reporter.  Concomitant products included HCTZ for Blood pressure, CITALOPRAM for Depression, METFORMIN and DULAGLUTIDE (TRULICITY) for Diabetes, LEVOTHYROXINE for Thyroid therapy.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red circle on the arm until 19Apr2021). On 19-Apr-2021, VACCINATION SITE ERYTHEMA (red circle on the arm until 19Apr2021) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were reported.    Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: No new information
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling, Pyrexia, Swelling
Clinical narrative: swelling; under her arm and in her arm pit started swelling and throbbing; under her arm and in her arm pit started swelling and throbbing; fever; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), PERIPHERAL SWELLING (under her arm and in her arm pit started swelling and throbbing), PAIN (under her arm and in her arm pit started swelling and throbbing) and PYREXIA (fever) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020. Concomitant products included HYDROCHLOROTHIAZIDE and NIFEDIPINE for an unknown indication.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced SWELLING (swelling), PERIPHERAL SWELLING (under her arm and in her arm pit started swelling and throbbing), PAIN (under her arm and in her arm pit started swelling and throbbing) and PYREXIA (fever). At the time of the report, SWELLING (swelling), PERIPHERAL SWELLING (under her arm and in her arm pit started swelling and throbbing), PAIN (under her arm and in her arm pit started swelling and throbbing) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported. On 17-Apr-2021 she stated that under her arm and in her arm pit started swelling and was throbbing, she also stated that the pain has not increased since the symptoms began. She also experienced fever and more swelling. She also reported that she previously had COVID-19 back in December and wanted to know if this was a normal side effect and how she should be treating it.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: black and blue mark on his arm; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (black and blue mark on his arm) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040321A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced SKIN DISCOLOURATION (black and blue mark on his arm). At the time of the report, SKIN DISCOLOURATION (black and blue mark on his arm) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No other relevant concomitant medication were reported.  No treatment information was reported.  As per the received TCR follow up document reporter stated that patient had taken 2nd dose and no additional adverse events were observed.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Significant follow up received, Event outcome was updated.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dehydration, Fatigue, Headache
Clinical narrative: "hands and body shaken; felt onstantly thirsty; terrible chills; severe joint pain; nausea; fatigue; slide headache; sore arm; little soreness in injection site; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR ("hands and body shaken), DEHYDRATION (felt onstantly thirsty), VACCINATION SITE PAIN (little soreness in injection site), FATIGUE (fatigue) and HEADACHE (slide headache) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included LISINOPRIL, SIMVASTATIN and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE PAIN (little soreness in injection site). On 16-Apr-2021, the patient experienced FATIGUE (fatigue), HEADACHE (slide headache) and ARTHRALGIA (sore arm). On 17-Apr-2021, the patient experienced TREMOR ("hands and body shaken), CHILLS (terrible chills), ARTHRALGIA (severe joint pain) and NAUSEA (nausea). 17-Apr-2021, the patient experienced DEHYDRATION (felt onstantly thirsty). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 20-Mar-2021, VACCINATION SITE PAIN (little soreness in injection site) had resolved. On 17-Apr-2021, FATIGUE (fatigue), HEADACHE (slide headache) and ARTHRALGIA (sore arm) had resolved. On 18-Apr-2021, TREMOR ("hands and body shaken), DEHYDRATION (felt onstantly thirsty), CHILLS (terrible chills), ARTHRALGIA (severe joint pain) and NAUSEA (nausea) had resolved.            The action taken with the drug was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-080446 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080446:FIRST DOSE
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Tremor, Vaccination site pain
Clinical narrative: "hands and body shaken; felt onstantly thirsty; terrible chills; severe joint pain; nausea; fatigue; slide headache; sore arm; little soreness in injection site; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR ("hands and body shaken), DEHYDRATION (felt onstantly thirsty), VACCINATION SITE PAIN (little soreness in injection site), FATIGUE (fatigue) and HEADACHE (slide headache) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided.  Concomitant products included LISINOPRIL, SIMVASTATIN and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE PAIN (little soreness in injection site). On 16-Apr-2021, the patient experienced FATIGUE (fatigue), HEADACHE (slide headache) and ARTHRALGIA (sore arm). On 17-Apr-2021, the patient experienced TREMOR ("hands and body shaken), CHILLS (terrible chills), ARTHRALGIA (severe joint pain) and NAUSEA (nausea). 17-Apr-2021, the patient experienced DEHYDRATION (felt onstantly thirsty). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 20-Mar-2021, VACCINATION SITE PAIN (little soreness in injection site) had resolved. On 17-Apr-2021, FATIGUE (fatigue), HEADACHE (slide headache) and ARTHRALGIA (sore arm) had resolved. On 18-Apr-2021, TREMOR ("hands and body shaken), DEHYDRATION (felt onstantly thirsty), CHILLS (terrible chills), ARTHRALGIA (severe joint pain) and NAUSEA (nausea) had resolved.            The action taken with the drug was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-080446 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080446:FIRST DOSE
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Eyelid irritation, Ocular discomfort
Clinical narrative: Drooping eyelid, the same side where she got the shot, that last for 24 hours; Could not close left eye; Most severe dizziness , which was never happened in her life, last for 10-15min; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Most severe dizziness , which was never happened in her life, last for 10-15min), EYELID IRRITATION (Drooping eyelid, the same side where she got the shot, that last for 24 hours) and OCULAR DISCOMFORT (Could not close left eye) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (Most severe dizziness , which was never happened in her life, last for 10-15min). On 07-Apr-2021, the patient experienced EYELID IRRITATION (Drooping eyelid, the same side where she got the shot, that last for 24 hours) and OCULAR DISCOMFORT (Could not close left eye). On 06-Apr-2021, DIZZINESS (Most severe dizziness , which was never happened in her life, last for 10-15min) had resolved. On 08-Apr-2021, EYELID IRRITATION (Drooping eyelid, the same side where she got the shot, that last for 24 hours) and OCULAR DISCOMFORT (Could not close left eye) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Eye irritation, Fatigue, Hypersomnia
Clinical narrative: Condition aggravated; Allergies; Eyes  was burning; Checked  her oxygen and was little low; She slept more; Mild cough; More fatigue/ tiredness; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Condition aggravated), MULTIPLE ALLERGIES (Allergies), EYE IRRITATION (Eyes  was burning), OXYGEN SATURATION DECREASED (Checked  her oxygen and was little low) and HYPERSOMNIA (She slept more) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD and Seasonal allergy (Patient has nose running constantly, little cough, eyes burning  due to spring.).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (Condition aggravated), MULTIPLE ALLERGIES (Allergies), EYE IRRITATION (Eyes  was burning), OXYGEN SATURATION DECREASED (Checked  her oxygen and was little low), HYPERSOMNIA (She slept more), COUGH (Mild cough) and FATIGUE (More fatigue/ tiredness). At the time of the report, CONDITION AGGRAVATED (Condition aggravated), MULTIPLE ALLERGIES (Allergies), EYE IRRITATION (Eyes  was burning), OXYGEN SATURATION DECREASED (Checked  her oxygen and was little low), HYPERSOMNIA (She slept more), COUGH (Mild cough) and FATIGUE (More fatigue/ tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Oxygen saturation: normal (normal) Patient checked her oxygen  level was fine. On 08-Apr-2021, Oxygen saturation: low (Low) After second dose patient oxygen was low.          No treatment information was provided. No relevant concomitant medications were reported.   This case was linked to MOD-2021-080402 (Patient Link).